|
|
Application value of noninvasive positive pressure ventilation in emergency treatment of acute respiratory failure |
KE Wei-guang CHEN Zhen-rong |
Department of Emergency,Maoming People′s Hospital in Guangdong Province,Maoming 525000,China |
|
|
Abstract Objective To explore the application value of non-invasive positive pressure ventilation(NIPPV)in the emergency treatment of acute respiratory failure.Methods From December 2017 to December 2019,116 patients with acute respiratory failure admitted to Maoming People′s Hospital in Guangdong Province were selected and divided into control group and experimental group according to random number table method,58 cases in each group.Patients in the control group were given conventional symptomatic supportive therapy,and patients in the experimental group were given NIPPV on basic of the control group.The clinical effect,clinical mortality,incidence of ventilator pneumonia,and various indicators of patients before and after treatment were compared between the two groups.Results The total treatment efficiency of the experimental group was 93.10%,which was higher than 74.14% of the control group,and the difference was statistically significant(P<0.05).The mortality and the incidence of ventilator pneumonia in the experimental group were 1.72% and 6.90%,respectively.Compared with 13.79% and 25.86% of the control group,the differences were statistically significant(P<0.05).After treatment,the partial oxygen pressure(PaO2)and blood pH were(79.89±10.98)mmHg and(7.35±0.03)in the experimental group,which were higher than those in the control group of(63.61±7.95)mmHg and(7.26±0.03),and the differences were statistically significant(P<0.05).Carbon dioxide partial pressure(PaCO2),heart rate(HR),and respiratory rate(RR)levels in the experimental group were(44.45±4.19)mmHg,(21.66±6.19)times/min,and(101.34±21.58)times/min,which were lower than those in the control group of(58.47±6.31)mmHg,(26.53±8.69)times/min,and(113.88±21.72)times/min,the differences were statistically significant(P<0.05).Conclusion The application of in the emergency treatment of acute respiratory failure can reduce the incidence of death and complications,effectively improve the patients′ indicators,alleviate the patients′ symptoms,and has significant curative effect.
|
|
|
|
|
[2] |
陈春芬,徐德祥.滴定呼气灵敏度在AECOPD 合并呼吸衰竭患者无创正压通气治疗中的应用[J].山东医药,2017,57(6):54-56.
|
[3] |
谈定玉,凌冰玉,孙家艳,等.经鼻高流量氧疗与无创正压通气比较治疗慢性阻塞性肺疾病合并中度呼吸衰竭的观察性队列研究[J].中华急诊医学杂志,2018,27(4):361-365.
|
[4] |
程宁,彭爽.夜间无创正压通气治疗慢性阻塞性肺疾病合并高碳酸血症呼吸衰竭患者的疗效[J].中国老年学杂志,2018,38(5):1117-1119.
|
[5] |
胡述立,汤浩,范学朋.经鼻高流量氧疗与无创正压通气在不同APACHEⅡ评分老年AECOPD 患者中拔管后的治疗效果研究[J].中国全科医学,2018,21(15):33-38.
|
[6] |
陶琳,万群芳,吴小玲,等.四川省30 家综合医院无创正压通气治疗过程中供氧浓度和吸入氧浓度的调查研究[J].中国现代医学杂志,2018,28(6):65-70.
|
[7] |
沈杰.无创正压通气在急性呼吸衰竭患者急诊治疗中的作用研究[J].基层医学论坛,2019,23(25):3620-3622.
|
[8] |
贾想丽,闫慈,徐思成,等.免疫抑制患者合并急性呼吸衰竭时无创正压通气治疗失败的预警分析[J].中华危重病急救医学,2018,30(2):107-111.
|
[9] |
王维樟,汪利华,何玉萍.无创正压通气治疗COPD 急性加重期伴呼吸衰竭的临床观察[J].中国实用医刊,2018,45(3):57-59.
|
[10] |
肖亮.无创正压通气在急性呼吸衰竭急诊治疗中的应用研究[J].中国医疗设备,2017,32(S1):76-77.
|
[11] |
陈太碧,文英旭,邢柏.无创正压通气对急性呼吸衰竭患者的临床价值[J].检验医学与临床,2017,14(14):2059-2060.
|
[12] |
李昌龙,胡小芬,胡双妹,等.急诊无创正压通气对急性呼吸衰竭的治疗效果观察[J].基层医学论坛,2017,21(2):180-181.
|
[13] |
鄞松峰.无创正压通气在对急性呼吸衰竭患者进行抢救中的应用价值[J].当代医药论丛,2018,16(9):101-102.
|
[1] |
杨平,蒲亨萍,刘榜英,等.无创正压通气治疗对急性呼吸衰竭患者拔管后再插管和病死情况的影响[J].中国现代医学杂志,2018,28(30):94-98.
|
[14] |
张治.无创正压通气联合盐酸纳洛酮注射液治疗慢性阻塞性肺疾病急性加重期并呼吸衰竭的临床疗效及其对患者肺功能和生活质量的影响[J].实用心脑肺血管病杂志,2016,24(7):47-50.
|
[15] |
陈海涛.无创正压通气在急性呼吸衰竭急诊治疗中的应用价值分析[J].中国实用医药,2019,14(34):44-45.
|
|
|
|